Medicaid spending on autism therapy quintupled since 2021, raising fraud concerns

Medicaid has urged states to increase oversight of applied behaviour analysis therapy for autism after spending on it quintupled since 2021, far outstripping growth in diagnoses. The discrepancy has raised concerns about overprescribing and potential fraud within the programme. Federal authorities are worried about possible misuse of public funds.